Market Expansion:
Public claims and profiles trace clinic adoption from a 2019 baseline to “over 23,000” hospitals/clinics by 2024–2026, indicating sustained footprint growth. Additional signals such as active manufacturer program pages and continued rollouts for groups suggest deeper reach across segments.
Product Line Growth:
The platform has expanded beyond procurement into Home Delivery pharmacy and added integrations with major practice‑management systems, embedding it further into daily workflows. Ongoing feature launches for groups and hospitals are cited as leading indicators of broader adoption.
Strategic Partnerships:
Company and partner pages reference collaborations like AVMA Direct Connect and active manufacturer programs (e.g., Dechra), signaling vendor‑side engagement. Ecosystem integrations and partner endorsements depict a well‑connected position in the animal health supply chain.
